Where can researchers source third-party tested Melanotan I?

Midwest Peptide supplies research-grade Melanotan I with a Certificate of Analysis included for every batch, validated by HPLC purity and mass spectrometry identity testing.

Age Verification

You must be 21 years or older to access this website. All products are for research use only.

Are you 21 years of age or older?

By entering, you confirm that you are at least 21 years old and agree to our terms of service.

Free shipping on every orderFree shipping on every order

5% off with Zelle or Apple CashSave an extra 5% when you pay with Zelle or Apple Cash

Bulk pricing discounts up to 18%Bulk pricing discounts up to 18% off

Melanotan I Photoprotection Research | Midwest Peptide

Melanotan I Eumelanin vs Pheomelanin Research: Tyrosinase Pathway StudiesPrev|Where to Buy Cagrilintide for Research: Amylin Analog Sourcing GuideNext

Melanotan I Photoprotection Research: UV-Induced Damage Animal Model Studies

Q: Is Melanotan I approved for human use?

No. Melanotan I is not approved by the FDA for any human therapeutic use. It is supplied strictly for in-vitro and preclinical research purposes by qualified investigators.

Melanotan I · Published April 14, 2026 · Updated May 18, 2026 · 7 min read

Quick Answer

Melanotan I photoprotection research examines UV-induced damage reduction and MC1R-mediated melanin synthesis in rodent skin models. Studies measure DNA damage markers like CPDs, oxidative stress biomarkers, and photoprotective melanin accumulation across standardized UV exposure research protocols. For research use only, not for human consumption.

Melanotan I Photoprotection Research: UV-Induced Damage Animal Model Studies

Research Use Only. All products are strictly for research use only (RUO). Not for human consumption. Products on this site are not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the FDA. By purchasing, you agree that you are a qualified researcher and that products will be used solely for in-vitro research purposes.

UV Induced Skin Damage Biology
Photoprotection Research in Rodent Models
The Eumelanin Shift
Erythropoietic Protoporphyria Context
Gene Expression in Photoprotection Research
Relationship to Melanotan II Research
Research Design for Photoprotection Studies
Research Peptide Referenced
Related Research Reading
Related Research Articles
Explore Related Products
Frequently Asked Questions
Glossary

Melanotan I photoprotection research is the direct clinical and preclinical application of MC1R receptor activation biology that anchors the Melanotan I research cluster. UV induced skin damage has been studied extensively in animal models with MT-1, and the photoprotection endpoints provide research context for the clinical lipodystrophy research covered in the afamelanotide EPP research article. This article reviews the photoprotection literature in rodent research models and connects it to the mechanistic foundation in MC1R and melanogenesis research.

Frequently Asked Questions

What is Melanotan I in research contexts?

Melanotan I (afamelanotide) is a synthetic 13-amino-acid analog of alpha-melanocyte-stimulating hormone (alpha-MSH) with high MC1R selectivity. It is studied in preclinical research and clinical literature for melanogenesis, photoprotection, and erythropoietic protoporphyria.

How does Melanotan I provide photoprotection in animal models?

Pre-treatment with Melanotan I in rodent models elevates skin eumelanin content, providing UV-absorbing pigmentation that reduces UV-induced erythema, DNA damage (cyclobutane pyrimidine dimers), and inflammatory responses upon subsequent UV challenge.

What UV damage endpoints are measured in Melanotan I research?

Endpoints include erythema scoring, DNA photoproduct formation, oxidative DNA damage markers, sunburn cell counts on histology, and longer-term endpoints like skin thickening, photoaging features, and neoplastic changes in chronic UV exposure protocols.

Is Melanotan I approved for human use?

Glossary

Key terms used in this article.

MC1R: Melanocortin 1 receptor, the primary GPCR on melanocytes that signals melanin synthesis upon alpha-MSH binding.
Melanogenesis: The biochemical pathway producing melanin from tyrosine within melanosomes of melanocytes.
Eumelanin: The dark brown to black melanin pigment that provides photoprotective absorbance of UV radiation.
Tyrosinase: The rate-limiting copper-dependent enzyme catalyzing the first two steps of melanin biosynthesis from tyrosine.
Erythropoietic Protoporphyria (EPP): A rare genetic disorder of heme biosynthesis causing severe photosensitivity, the indication for clinical afamelanotide use.
Cyclobutane Pyrimidine Dimer (CPD): A UV-induced covalent bond between adjacent pyrimidine bases, the dominant DNA photoproduct from UVB exposure.
Sunburn Cell: An apoptotic keratinocyte in UV-exposed epidermis, identifiable histologically and used as a marker of acute UV damage.

More from the Blog

Continue exploring research insights and updates.

Subcutaneous vs Intranasal: Choosing an Administration Route for DSIP, Selank, and Kisspeptin in Research

Subcutaneous vs intranasal administration for CNS-targeted research peptides: how to choose between routes for DSIP, Selank, and Kisspeptin based on molecular size, brain access, pharmacokinetics, and the published literature.

May 5, 2026

Can I Still Buy Compounded Tirzepatide? (2026 Research Context)

FDA restricted compounded tirzepatide for human use when the shortage ended. The Research Use Only research peptide channel for tirzepatide (GLP-2 TZ) operates under entirely separate regulations.

May 5, 2026

For Research Use Only. Melanotan I is intended strictly for in vitro and preclinical animal research. It is not approved for human use, is not a drug, and should never be administered to humans.

UV Induced Skin Damage Biology

Ultraviolet radiation damages skin at multiple biological levels. UVA and UVB wavelengths generate reactive oxygen species through direct photochemistry and through the activation of endogenous photosensitizers. The reactive oxygen species damage cellular lipids, proteins, and DNA. The DNA damage is particularly important because UVB directly induces cyclobutane pyrimidine dimers that are premutagenic lesions, and unrepaired DNA damage contributes to photoaging and to photocarcinogenesis.

The skin has several endogenous defenses against UV damage. Melanin pigmentation is the most prominent defense, acting as a broad spectrum optical filter that reduces UV penetration into basal epidermal layers. Antioxidant enzymes including superoxide dismutase, catalase, and glutathione peroxidase scavenge reactive oxygen species. DNA repair enzymes including photolyases and nucleotide excision repair machinery remove the direct photochemical lesions. The integrated defensive capacity of the skin determines the threshold at which UV exposure produces measurable damage. The Nature subject hub on photoprotection archives primary research on these mechanisms.

Melanotan I as a research compound activates the MC1R receptor, which stimulates melanin synthesis and shifts the balance of melanin production toward the photoprotective eumelanin form. Research on MT-1 photoprotection therefore examines the functional consequences of enhanced melanin production on the skin's response to UV damage.

Photoprotection Research in Rodent Models

Rodent photoprotection research uses defined UV exposure protocols followed by quantification of damage endpoints. The standard endpoints include histological damage scoring, DNA damage measurements including cyclobutane pyrimidine dimer quantification, oxidative damage markers, and longer term outcomes including photoaging morphology and skin cancer incidence.

Published MT-1 research in rodent models documents reductions in UV damage endpoints compared to untreated controls. The magnitude of photoprotection depends on the specific rodent strain, the UV exposure parameters, the dosing regimen, and the outcome measured. Larger effects are generally observed with protocols that produce significant baseline damage, allowing greater dynamic range for the photoprotective intervention to show effect.

The mechanism of photoprotection under MT-1 involves enhanced melanin synthesis in response to MC1R receptor activation. The increased melanin content of the epidermis provides greater optical filtering of incident UV radiation, which reduces the dose of UV reaching the basal layer keratinocytes and melanocytes where the most damaging effects occur. The Cell Press journal Cell Reports Medicine and the ScienceDirect melanin topic page both archive primary research on the biology of UV filtering by melanin.

The Eumelanin Shift

A key feature of MC1R mediated photoprotection is the preferential production of eumelanin rather than pheomelanin. These are the two main forms of melanin, and they have different photoprotective properties. Eumelanin is the darker brown black form that provides better UV filtering and is more stable against photo oxidation. Pheomelanin is the reddish yellow form that provides less UV filtering and can itself generate reactive oxygen species under UV exposure.

The balance between eumelanin and pheomelanin is regulated by MC1R signaling. Active MC1R signaling favors eumelanin production through activation of the microphthalmia associated transcription factor and through upregulation of the enzymes in the eumelanin branch of the melanogenesis pathway. The detailed biochemistry is covered in the eumelanin versus pheomelanin article in this cluster.

For photoprotection research, the eumelanin shift means that MT-1 administration not only increases total melanin content but also shifts the melanin composition toward the more protective form. This qualitative change adds to the quantitative increase in melanin to produce a combined photoprotective effect that is larger than what either change alone would produce.

Erythropoietic Protoporphyria Context

The most extensively studied clinical photoprotection application of afamelanotide, the pharmaceutical name for Melanotan I, is in erythropoietic protoporphyria. This rare genetic disorder produces severe phototoxicity due to the accumulation of protoporphyrin IX in skin and other tissues, and affected individuals experience intense pain upon sun exposure. The clinical trial literature on afamelanotide in erythropoietic protoporphyria is reviewed in the afamelanotide EPP research article in this cluster.

The preclinical photoprotection research provides mechanistic context for the clinical findings. The shared mechanism of enhanced melanin production and shifted eumelanin composition explains why the compound is effective in protecting against phototoxicity. The research and clinical contexts are mechanistically continuous, and findings in one support interpretation of the other.

Gene Expression in Photoprotection Research

Transcriptomic analysis of skin from MT-1 treated rodents documents changes in gene expression that support the photoprotection findings. Melanogenesis gene expression is upregulated, including tyrosinase, tyrosinase related protein 1, and dopachrome tautomerase. Antioxidant gene expression including Nrf2 target genes is upregulated in some studies, providing additional defense against oxidative damage. DNA damage response gene expression shifts toward more efficient repair.

The integrated gene expression signature is consistent with a coordinated photoprotective response that extends beyond simple melanin production. The Wiley Online Library dermatology collection and the Frontiers in Physiology dermatology section archive primary research on the integrated genomic response to MC1R signaling.

Relationship to Melanotan II Research

The companion Melanotan II research cluster covers MT-2, which is a cyclic analog with broader melanocortin receptor affinity including MC4R and other receptors beyond MC1R. For photoprotection specifically, MT-1 and MT-2 both stimulate MC1R signaling and produce similar pigmentation effects, but they differ in the off target effects from the broader receptor coverage of MT-2.

Research that specifically wants to isolate the MC1R mediated photoprotection effect uses MT-1 because of its greater receptor selectivity. Research that wants to examine broader melanocortin effects uses MT-2. The MT-1 versus MT-2 comparison article in this cluster provides the detailed analysis of the comparative pharmacology.

Research Design for Photoprotection Studies

Research design for photoprotection studies involves several specific considerations. The UV source should be characterized for wavelength and dose delivery. The rodent model should be selected to match the research question, with different pigmentation backgrounds producing different baseline photoprotection and different dynamic ranges for intervention effects. Pre-treatment with MT-1 should be long enough to allow melanin synthesis to respond before UV challenge, which requires days rather than hours of lead time.

Endpoint selection should match the research question. Acute endpoints include erythema, DNA damage markers, and oxidative damage. Chronic endpoints include photoaging morphology, chronic inflammation markers, and photocarcinogenesis incidence. Each endpoint category requires different study duration and different quantitative methods.

Research Peptide Referenced

MT-1 10mg, research grade Melanotan I, lyophilized powder, third party certificate of analysis

For complete sourcing information, see the Melanotan I sourcing guide in this cluster.

Within the MT-1 cluster:

Related cluster pillars:

Not for human consumption. Research use only.

Explore more peer-reviewed research and laboratory guides from our science team:

All products are third-party tested with a Certificate of Analysis (COA) included. For research use only.

Glutathione 1500mg, 99%+ purity, COA included
MT-1 10mg, 99%+ purity, COA included
MT-2 10mg, 99%+ purity, COA included
GHK-Cu 50mg, 99%+ purity, COA included
Bacteriostatic Water, 99%+ purity, COA included

Browse All Research Peptides →

Age Verification

Melanotan I Photoprotection Research: UV-Induced Damage Animal Model Studies

Frequently Asked Questions

What is Melanotan I in research contexts?

How does Melanotan I provide photoprotection in animal models?

What UV damage endpoints are measured in Melanotan I research?

Is Melanotan I approved for human use?

Glossary

More from the Blog

Subcutaneous vs Intranasal: Choosing an Administration Route for DSIP, Selank, and Kisspeptin in Research

Can I Still Buy Compounded Tirzepatide? (2026 Research Context)

UV Induced Skin Damage Biology

Photoprotection Research in Rodent Models

The Eumelanin Shift

Erythropoietic Protoporphyria Context

Gene Expression in Photoprotection Research

Relationship to Melanotan II Research

Research Design for Photoprotection Studies

Research Peptide Referenced

Ready to Start Your Research?

Where can researchers source third-party tested Melanotan I?

What's the Cheapest Way to Get Tirzepatide (GLP-2 TZ) for Research?

Age Verification

Melanotan I Photoprotection Research: UV-Induced Damage Animal Model Studies

Frequently Asked Questions

What is Melanotan I in research contexts?

How does Melanotan I provide photoprotection in animal models?

What UV damage endpoints are measured in Melanotan I research?

Is Melanotan I approved for human use?

Glossary

More from the Blog

Subcutaneous vs Intranasal: Choosing an Administration Route for DSIP, Selank, and Kisspeptin in Research

Can I Still Buy Compounded Tirzepatide? (2026 Research Context)

UV Induced Skin Damage Biology

Photoprotection Research in Rodent Models

The Eumelanin Shift

Erythropoietic Protoporphyria Context

Gene Expression in Photoprotection Research

Relationship to Melanotan II Research

Research Design for Photoprotection Studies

Research Peptide Referenced

Related Research Reading

Related Research Articles

Explore Related Products

Ready to Start Your Research?

Where can researchers source third-party tested Melanotan I?

What's the Cheapest Way to Get Tirzepatide (GLP-2 TZ) for Research?